Alexion Pharmaceuticals Recalls Certain Lots of Soliris

June 2, 2014 11:49 AM

14 0

Alexion Pharmaceuticals Inc. (ALXN) said it is initiating a voluntary recall of certain lots of its Soliris concentrated solution for intravenous infusion due to the presence of visible particles.

The company said the recall was initiated because certain particles were detected in a single lot of Soliris during periodic stability testing of the treatment.

Read more

To category page